India Pharma Outlook Team | Thursday, 30 October 2025
US direct sales market leader Amway will pump in $12 million in India in the next three to five years to expand retail reach and deepen distribution network.
The decision is in line with Amway's increasing focus on India, which it seeks to transform into one of its world's top three markets, its President and Global CEO Michael Nelson said.
Addressing during his maiden trip to India after becoming president, Nelson announced that the new investment would be used to launch new Amway stores throughout the nation, which would be community centers for product experience, training, and customer interaction. The move is intended at improving the business owners' skill of Amway as well as the total customer experience.
Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation
Nelson highlighted that India remains a high-potential growth market, backed by strong demographics and an entrepreneurial spirit. ,"We've invested USD 140 million into this market in our history and we have future investments we're making as well," he said. The company operates four R&D labs and a shared services center in India, contributing to its global product development.
Amway has also established India as a major manufacturing base, second only to the US and China. Madurai has a plant that manufactures the full line of products for India's domestic market and exports for South East Asia. The company is doing business with 29 certified organic farms in India as sources of raw material of its Nutrilite nutrition business.
Nelson reaffirmed Amway's commitment to collaboration with the Indian government, applauding in favor of direct selling and ease of business and ensuring priority to health, wellness, and sustainable development.